eli lilly and company zepbound

Eli Lilly cuts prices for Zepbound weight-loss drug

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

Hosted on MSN · 1d

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

STAT · 2d

Eli Lilly to lower price of Zepbound vials, offer more doses

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells.

18hon MSN

Eli Lilly plans to invest $27B to build four new US plants as tariffs loom

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

22hon MSN

Eli Lilly to spend $27 billion to expand U.S. manufacturing with four new sites

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...

21h

Eyeing Trump trade policy shakeup, Eli Lilly to build 4 US factories

US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the United States in a committment designed to influence upcoming Trump administrati ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Eli Lilly cuts prices for Zepbound weight-loss drug

Trending now